Open Source Drug Discovery

Open Source Drug Discovery

Open Source Drug Discovery is a Council of Scientific and Industrial Research, India-led Team India Consortium with global participation offering a collaborative drug discovery platform for neglected tropical diseases like leishmaniasis, which draw limited attention of research-based pharmaceutical enterprises. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Open Source Drug Discovery, India, covering academic research published from 2001 to 2024. Read More.


Open Access Percentage

57%


Total
Publications

129


Total Open
Publications

73


Total
Citations

2K


Open Access
Percentage

57%


Total
Publications

129


Total Open
Publications

73


Total
Citations

2K

Wikipedia

Website

download

Breakdown

20% 33% 1% 46%

Publisher Open

20%

Both

33%

Other Platform Open

1%

Closed

46%

Percentage of Open Access over time

200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618Total Publications
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

52%OA Journal

OA Journal 52%

33

Hybrid 23%

15

No Guarantees 25%

16

Other Platform Open

Domain 71%

30

Institution 24%

10

Other Internet 21%

9

Public 10%

4

Preprint 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
31
DOI
Other Internet
9
Europe PMC
Domain
5
Figshare
Public
4
University of Denver - Digital Commons - DU
Institution
2
ORA - Oxford University Research Archive
Institution
2
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
2
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI
Institution
1
SwissUniversities - Journal of Eye Movement Research
Institution
1
SRCE - University of Zagreb University Computing Centre
Institution
1
1 / 2

Data updated 18 August 2025

Share

Share

Share